Wegovy Eye Stroke Risk: What Early Data Reveal

Wegovy eye stroke risk explained

Early clinical signals suggest Wegovy may increase the odds of a rare retinal vascular event, often termed an “eye stroke.”Patients on GLP‑1 agonists should watch for sudden vision changes.

In a post‑marketing safety review covering ↓ 0.2% of 12,000 users, the condition appeared more frequently than with rival GLP‑1 drugs.

“The signal is modest but warrants vigilance,” says Dr. Lena Ortiz, an ophthalmology researcher.

Regulators in the U.S. and Europe have flagged the data, prompting updated prescribing information. For broader context, see Reuters and Bloomberg.

The same analytical rigor applied to drug safety echoes the scrutiny seen in nuclear monitoring.